Imunon, Inc. (IMNN) stock
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.63−0.01 (-1.22%)
Close on Nov 13, 2026Market cap $3.53MP/E –Yield –
Imunon enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Imunon's enterprise value was -$1.98M on Nov 11, 2026, against $6.63M a year earlier. Over the last 5 years it ranged from -$1.98M to $560.90M, with a median of $97.65M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$1.98M | -134.4% |
| 2025 | Dec 31, 2025 | $5.73M | -96.6% |
| 2024 | Dec 31, 2024 | $169.37M | +166.4% |
| 2023 | Dec 29, 2023 | $63.58M | -31.6% |
| 2022 | Dec 30, 2022 | $92.91M | -83.4% |
| 2021 | Dec 31, 2021 | $560.90M | +74.4% |
| 2020 | Dec 31, 2020 | $321.60M | -33.1% |
| 2019 | Dec 31, 2019 | $481.05M | +51.9% |
| 2018 | Dec 31, 2018 | $316.77M | +9.5% |
| 2017 | Dec 29, 2017 | $289.34M | +502.7% |
| 2016 | Dec 30, 2016 | $48.01M | – |
See a number that looks wrong?